<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the risk of all-cause mortality.</p
<p>Comparison of changes in hemoglobin A1c values between the placebo and metformin groups during th...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1<50%) of LABAs compared with placebo.</...
<div><p>Background</p><p>Edoxaban recently proved non-inferior to warfarin for prevention of thrombo...
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
<p>Comparison of new oral anticoagulants versus imputed placebo on the risk of stroke.</p
<p>Comparison of new oral anticoagulants versus imputed placebo on the risk of stroke.</p
<p>Meta-analysis of fatal cardiovascular events in RCTs of LABAs compare with placebo.</p
<p>Studies are grouped by type of anticoagulant. Weight is the relative contribution of each study t...
<p>Meta-analysis of all trials comparing clopidogrel plus aspirin with aspirin plus placebo or aspir...
Background: Edoxaban recently proved non-inferior to warfarin for prevention of thromboembolism in p...
<p>Meta-analysis of fatal cardiovascular events in short-term RCTs of LABAs compared with placebo.</...
<p>Studies are grouped by type of anticoagulant. Weight is the relative contribution of each study t...
Purpose Vitamin K antagonists (VKAs) are the standard of care for stroke prevention in patients with...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1≥50%) of LABAs compared with placebo.</...
<p>Meta-analysis of fatal cardiovascular events in long-term RCTs of LABAs compared with placebo.</p
<p>Comparison of changes in hemoglobin A1c values between the placebo and metformin groups during th...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1<50%) of LABAs compared with placebo.</...
<div><p>Background</p><p>Edoxaban recently proved non-inferior to warfarin for prevention of thrombo...
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
<p>Comparison of new oral anticoagulants versus imputed placebo on the risk of stroke.</p
<p>Comparison of new oral anticoagulants versus imputed placebo on the risk of stroke.</p
<p>Meta-analysis of fatal cardiovascular events in RCTs of LABAs compare with placebo.</p
<p>Studies are grouped by type of anticoagulant. Weight is the relative contribution of each study t...
<p>Meta-analysis of all trials comparing clopidogrel plus aspirin with aspirin plus placebo or aspir...
Background: Edoxaban recently proved non-inferior to warfarin for prevention of thromboembolism in p...
<p>Meta-analysis of fatal cardiovascular events in short-term RCTs of LABAs compared with placebo.</...
<p>Studies are grouped by type of anticoagulant. Weight is the relative contribution of each study t...
Purpose Vitamin K antagonists (VKAs) are the standard of care for stroke prevention in patients with...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1≥50%) of LABAs compared with placebo.</...
<p>Meta-analysis of fatal cardiovascular events in long-term RCTs of LABAs compared with placebo.</p
<p>Comparison of changes in hemoglobin A1c values between the placebo and metformin groups during th...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1<50%) of LABAs compared with placebo.</...
<div><p>Background</p><p>Edoxaban recently proved non-inferior to warfarin for prevention of thrombo...
DOI
Add to ORKG